Difference between revisions of "Chuang Lab"
Line 8: | Line 8: | ||
</div> | </div> | ||
<div class="jcarousel-item"> | <div class="jcarousel-item"> | ||
− | {{banner|direction=right|title=Research Topics|section=|image= | + | {{banner|direction=right|title=Research Topics|section=|image=4008px-Pdx.jpg|width=15%|quote=The lab uses computational and mathematical approaches to understand how genomes function and evolve. We develop and apply techniques from a variety of disciplines, including molecular evolution, artificial intelligence, and biophysical modeling. We are currently focused in two areas: 1) Cancer evolution in response to therapy, and 2) RNA-Level Gene Regulation.}} |
</div> | </div> | ||
<div class="jcarousel-item"> | <div class="jcarousel-item"> |
Revision as of 10:15, 1 June 2018
Chuang Lab
Our lab works on problems in the fields of computational biology and bioinformatics. We have studied a wide variety of topics in cancer genomics, gene regulation, and molecular evolution, with particular focuses in post-transcriptional regulation and tumor evolution.
The lab uses computational and mathematical approaches to understand how genomes function and evolve. We develop and apply techniques from a variety of disciplines, including molecular evolution, artificial intelligence, and biophysical modeling. We are currently focused in two areas: 1) Cancer evolution in response to therapy, and 2) RNA-Level Gene Regulation.
Chuang Lab Awarded U24 for Data Coordination Center for NCI PDXNet
Together with Seven Bridges Genomics, we have been awarded a National Cancer Institute grant to coordinate data sharing and analysis for the PDXNet. We are working with esteemed collaborators at institutes including MD Anderson, the Huntsman Institute at the University of Utah, Baylor College of Medicine, the Wistar Institute, and Washington University. For this project we will be analyzing hundreds of new and existing PDX samples toward the goal of developing a clinical trial based on patient-derived xenografts.
Openings
As of June 2018, we have two postdoctoral openings in cancer computational biology.